A study led by Tel Aviv University’s Dr. Noam Shomron of the Sackler School of Medicine has discovered that delivery of a combination of genetic therapy with chemotherapy to a primary tumor site is extremely effective in preventing breast cancer metastasis.
The research was carried out at TAU in collaboration with Massachusetts Institute of Technology, led at MIT by Dr. Natalie Artzi, and the students of both principal investigators. Data on human genetics were provided by Prof. Eitan Friedman of TAU’s Sackler Faculty of Medicine and Chaim Sheba Medical Center.
In a TEDxTalk event in August of this year, Dr. Shomron discussed the study with a group of colleagues.
The findings were also published in the September 19, 2016 online issue of Nature Communications.
One in eight women worldwide are diagnosed annually with the disease. Breast cancer is the second leading cause of cancer death among women.